Research ArticleAccepted Articles
Open Access
Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases
Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsk, Ann E. Clarke, Dianne Mosher, Todd Wilson, Megan Thomas, Claire Barber, Mark Harrison, Nick Bansback, Laurie Proulx, Dawn P. Richards and Gilaad G. Kaplan
The Journal of Rheumatology January 2023, jrheum.220697; DOI: https://doi.org/10.3899/jrheum.220697
Glen S. Hazlewood
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Ines Colmegna
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Carol Hitchon
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Paul R. Fortin
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Sasha Bernatsk
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Ann E. Clarke
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Dianne Mosher
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Todd Wilson
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Megan Thomas
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Claire Barber
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Mark Harrison
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Nick Bansback
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Laurie Proulx
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Dawn P. Richards
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Gilaad G. Kaplan
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. Arthritis Research Canada, Vancouver, British Columbia, Canada. The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada. Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Division de Rhumatologie, Département de Médecine, CHU de Québec - Université Laval, Québec City, Québec, Canada. Centre de Recherche ARThrite - Arthrite, Recherche et Traitements, Université Laval, Québec City, Québec, Canada. Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada. Canadian Arthritis Patient Alliance, Ontario, Canada. Sources of support: This work was supported by the Canadian Rheumatology Association; a Canadian Institutes of Health Research Operating Grant: COVID-19 Rapid Research Funding Opportunity [Funding Reference umber VR5-172684]; and the Public Health Agency of Canada through the Vaccine Surveillance Reference Group (VSRG) and the COVID-19 Immunity Task Force (CITY). Dr. Hazlewood is supported by a Canadian Institutes of Health Research New Investigator Award. Dr Fortin holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Harrison received salary support through a 2017 Scholar Award from the Michael Smith Foundation for Health Services Research. Correspondence to: Glen S Hazlewood, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N 4Z6, Canada. E-mail: gshazlew@ucalgary.ca.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 50, Issue 3
1 Mar 2023
Accepted manuscript
Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases
Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsk, Ann E. Clarke, Dianne Mosher, Todd Wilson, Megan Thomas, Claire Barber, Mark Harrison, Nick Bansback, Laurie Proulx, Dawn P. Richards, Gilaad G. Kaplan
The Journal of Rheumatology Jan 2023, jrheum.220697; DOI: 10.3899/jrheum.220697
Accepted manuscript
Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases
Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsk, Ann E. Clarke, Dianne Mosher, Todd Wilson, Megan Thomas, Claire Barber, Mark Harrison, Nick Bansback, Laurie Proulx, Dawn P. Richards, Gilaad G. Kaplan
The Journal of Rheumatology Jan 2023, jrheum.220697; DOI: 10.3899/jrheum.220697
